CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Alveogyldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05536115
NCT05536115N/ACompleted

Prospective, Multicentre Clinical Trial Measuring the Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket

Septodont·observational·Posted Sep 10, 2022·Updated May 14, 2026

In Brief

An observational study evaluating Alveogyl for Dry Socket. Completed, enrolled 120 participants across 16 sites in 2 countries.

Detailed Summary

Alveogyl (Septodont, Saint-Maur-des-Fossés - France) is a Medical Device used as dressing in case of dry socket. ALVE study is a clinical investigation measuring Alveogyl performance and safety in patients with post-extraction dry socket. The study takes place in India and in France where Alveogyl is already marketed, since 2010 in France and since 2014 in India .

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDry Socket
CountriesFrance, India

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 10, 2022
Enrollment StartDec 13, 2022
Primary CompletionJun 26, 2025
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 3.8 years ago

Interventions

Alveogyldevice

The patients will be treated by Alveogyl. Global treatment protocol (curettage, cleaning, local anaesthesia etc.) of the dry socket is at the discretion of the Investigator. Alveogyl is used as an alveolar dressing. Placement of Alveogyl (about 0.2 g of paste) into the dental socket is done according to its instruction for use by a dental professional only.